ClinicalTrials.gg
DrugBiological

Golimumab clinical trials

Also written Simponi and CNTO 148.

studies test it
72
open now
5
in phase 3
30
first study started
2003

How each study uses golimumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the golimumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Apr 2009 · SIMPONI · BLA 125289 (FDA, Drugs@FDA)
European Union
1 Oct 2009 · Simponi · EMEA/H/C/000992 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Golimumab
52
Golimumab 50 mg
5
Golimumab 100 mg
4
Golimumab 200 mg
2
Golimumab 2 mg/kg IV
2

Brand

Simponi
24

Development codes

CNTO 148
5
MK-8259
1

Studies by the year they started

72 studies that test it; most in 2013 (7)

Studies that test golimumab, by start year
YearStudies
20031
20041
20054
20062
20075
20082
20094
20105
20111
20125
20137
20146
20153
20163
20175
20183
20192
20204
20212
20223
20241
20251
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
6
Phase 2
19
Phase 3
30
Phase 4
16
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 44 · Other 28

Janssen Research & Development, LLC (15) · Centocor, Inc. (15) · Merck Sharp & Dohme LLC (6) · Janssen Pharmaceutical K.K. (2) · Janssen Biotech, Inc. (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Shanghai Mental Health Center (2) · The Leeds Teaching Hospitals NHS Trust (1)

Often tested with

Tested in the same studies.

Infliximab (8) · Methotrexate (7) · Etanercept (6) · Adalimumab (6) · Abatacept (4) · Certolizumab Pegol (4) · Guselkumab (3) · Ustekinumab (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Golimumab is the comparator. A study of two new drugs counts under both.

Studies

Open first, then newest update. How each study uses golimumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 72

See all 72 studies that test golimumab →

Given beside what is tested · 5 — golimumab is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with golimumab

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call golimumab · ClinicalTrials.gg INT005277

  • MeSH (NLM) C529000golimumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 91X1KLU43EGOLIMUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 819300Confirmed FDA, Wikidata
  • Wikidata Q413879golimumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87766GolimumabOne source FDA
  • DrugBank DB06674One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.